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scientists are challenged to develop such strategies in which the
aspect of electrical interaction is included and controlled.
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REPLY
We thank Dr. van Veen and colleagues for emphasizing the
importance of optimal electrical coupling between cells trans-
planted into ischemically damaged myocardium and host cardio-
myocytes. We fully agree that electrical integration of transplanted
cells into the acceptor myocardium is essential to: 1) prevent
occurrence of life-threatening arrhythmias; and 2) enhance the
contractile capacity through coordinated contraction of host car-
diomyocytes and transplanted cells.
Our recent in vitro model study, aimed at investigating the
electrophysiological properties of human mesenchymal stem cells
(MSCs), demonstrated connexin-mediated conduction of the ac-
tion potential across MSCs (1). In our opinion, the observed
impulse transmission (although mainly passive within the first 24
to 48 h) may be sufficient to prevent the occurrence of pro-
arrhythmogenic large excitable gaps in transplanted areas. This is
corroborated by the finding that at present no increased inducibility of
arrhythmias was reported after transplantation of autologous bone-
marrow–derived cells in patients with ischemic heart disease (2). In
particular, repetitive electrocardiographic monitoring after MSC
transplantation for acute myocardial infarction did not reveal
increased occurrence of arrhythmias (3). Long-term in vitro
recordings should elucidate whether conduction velocity, ampli-
tude, and depolarization rate of the MSC electrograms increase
48 h after MSC application.
van Veen and colleagues suggest that transplantation of MSCs
may not support the contractile capacity as MSCs injected in a rat
myocardial infarction model lacked a well-developed functional
contractile apparatus (4). However, a number of clinical studies
have reported on improved left ventricular ejection fraction after
bone marrow cell transplantation (2,3). Furthermore, it should be
emphasized that the mechanism by which bone-marrow–cell
transplantation improves cardiac function remains uncertain. The
MSC-induced improvement in left ventricular ejection fraction
described by Chen et al. (3) may either result from 1) differenti-
ation of MSCs into cardiomyocytes (which inherently support
myocardial contractility) or from 2) paracrine signaling by trans-
planted MSCs (which humorally stimulate the function of resident
or recruited cardiac [progenitor] cells) (5). Clearly, additional
research is warranted to provide more insight into the mechanism
of the contractile improvement after bone-marrow–cell transplan-
tation.
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The Other Face of the Medal:
The Risks of Exercise Training
I read with interest the recent study in the Journal by Noda et al.
(1) who concluded that exercise training might reduce the risk of
mortality from coronary heart disease and stroke in Asian popu-
lations. However, several limitations of the study need to be
considered. Indeed, except for walking, both intensive and pro-
longed exercises may have harmful effects on the cardiovascular
system regardless of the time spent participating in sporting
activities. In particular, acute heavy exercise may cause myocardial
ischemia, myocardial infarction, and cardiovascular stroke because
of suddenly increasing blood pressure, uncontrolled heart rate, and
oxygen demand (2). Noda et al. (1) should perhaps clarify the role
of intense physical activity in postponing mortality in the cardiac
patient.
Although there is strong epidemiological evidence that a dose-
response relationship exists between physical activity and all-cause
mortality, there is a consistent inverse dose-response relationship
between physical activity and both the incidence and mortality
220 Correspondence JACC Vol. 48, No. 1, 2006
July 4, 2006:219–25
rates from all types of cardiovascular and coronary heart disease
(3,4). Previously, it was reported that a U-shaped association
existed between physical activity and incidences of stroke or
mortality. In the Harvard Alumni Study, highly active men had
elevated stroke risk when compared with moderately active men
but lower risk when compared with low-active men (4). Contrary
to the investigators, a previously published study even showed a
positive association between physical activity and stroke incidence
in a Japanese population (5).
Moreover, data from an integrated activity questionnaire and
from recall diaries are converted to amount of energy expenditure,
but this may lead to a source of bias. Ideally, except for frequency
and duration components of physical activity, exercise intensity is
important for a preventative approach. The method carries many
difficulties, particularly for estimating different levels of physical
activity.
Related to these arguments is the following question: What is
the true path of the dose-response curve regarding physical activity
and cardiovascular mortality in cardiac patients (3)?
Finally, the intensity of physical activity should be taken into
consideration because it is a major contributor to exercise-induced
medical complications. The intensity of such activities should be
estimated and accurately prescribed to reduce health risks before
participation in sports exercises.
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REPLY
In reply to Dr. Kasikcioglu’s letter, our prospective study showed
that sports participation of 5 times per week was associated with
reduced risk of mortality from all cardiovascular and coronary heart
disease (1). We did not have any information on physical activity
intensity in our cohort. Also, our study did not provide informa-
tion on the role of physical activity in postponing mortality in
cardiac patients because we excluded subjects who had a history of
stroke, coronary heart disease, and/or cancer at baseline inquiry.
The U-shaped association between physical activity and stroke
mortality was not observed in the present study, probably because
the highest category of sports participation 5 times per week did
not necessarily represent high intensive exercises. However, as far
as sports participation, a potential benefit for reducing mortality
from stroke was weak and not statistically significant.
As Dr. Kasikcioglu pointed out, our data lacked information
regarding physical activity intensity, although a good correlation
existed between the frequency of sports participation and the
leisure-time physical activity score by the structural interview:
Spearman’s rank correlation was 0.53 in men and 0.58 in
women (2).
We agree with Dr. Kasikcioglu’s notion that the intensity of
physical activity is estimated and accurately prescribed to reduce
health risks before sports participation. Our data suggest that
sports participation, when prescribed properly, has a potential
benefit for reducing mortality from all cardiovascular and coronary
heart disease.
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Pediatric Cardiac Critical Care
Patients Should Be Cared for by Intensivists
We read with great interest the “Recommendations for Training in
Pediatric Cardiology” by Beekman et al. (1). As critical care
physicians from high-volume pediatric teaching hospitals with
large cardiac intensive care unit (ICU) patient populations, we
would like to comment specifically on the section describing
advanced training in Pediatric Cardiac Critical Care.
The practice of high-quality pediatric cardiac intensive care
requires a multidisciplinary collaboration between physicians (sur-
geon, cardiologist, intensivist, anesthesiologist, neonatologist) and
other clinical disciplines, such as nursing, respiratory therapy,
pharmacology, and nutrition support. Our comments are predi-
cated upon the well-established concept that critically ill patients,
including children, are best cared for by a multidisciplinary team of
clinicians with the intensivist as the team leader or co-leader (2–5).
Based upon data demonstrating better outcomes and decreased
costs of such a model, market forces like Leapfrog and the
National Quality Forum have mandated intensivist management
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